Cheng-Chin Chiang - Publications
Affiliations: | 2017-2019 | Biomedical Engineering | National Tsing Hua University, Hsinchu City, Taiwan, ROC |
Year | Citation | Score | |||
---|---|---|---|---|---|
2022 | Hsieh HT, Huang HC, Chung CW, Chiang CC, Hsia T, Wu HF, Huang RL, Chiang CS, Wang J, Lu TT, Chen Y. CXCR4-targeted nitric oxide nanoparticles deliver PD-L1 siRNA for immunotherapy against glioblastoma. Journal of Controlled Release : Official Journal of the Controlled Release Society. 352: 920-930. PMID 36334859 DOI: 10.1016/j.jconrel.2022.10.047 | 0.777 | |||
2020 | Huang KW, Hsu FF, Qiu JT, Chern GJ, Lee YA, Chang CC, Huang YT, Sung YC, Chiang CC, Huang RL, Lin CC, Dinh TK, Huang HC, Shih YC, Alson D, et al. Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer. Science Advances. 6: eaax5032. PMID 31998834 DOI: 10.1126/Sciadv.Aax5032 | 0.322 | |||
2019 | Lin CH, Wen HC, Chiang CC, Huang JS, Chen Y, Wang SK. Polyproline Tri-Helix Macrocycles as Nanosized Scaffolds to Control Ligand Patterns for Selective Protein Oligomer Interactions. Small (Weinheim An Der Bergstrasse, Germany). e1900561. PMID 30977296 DOI: 10.1002/Smll.201900561 | 0.431 | |||
2018 | Huang KW, Lai YT, Chern GJ, Huang SF, Tsai CL, Sung YC, Chiang CC, Hwang PB, Ho TL, Huang RL, Shiue TY, Chen Y, Wang SK. Galactose Derivative-Modified Nanoparticles for Efficient siRNA Delivery to Hepatocellular Carcinoma. Biomacromolecules. PMID 29808997 DOI: 10.1021/Acs.Biomac.8B00358 | 0.621 | |||
Show low-probability matches. |